Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201-Reference-Cited by-同舟云学术

Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

Published:2022-02 Issue: Volume:Volume 15 Page:911-925
ISSN:1178-7031
Container-title:Journal of Inflammation Research
language:en
Short-container-title:JIR

Author:

Kretzer Christian,Jordan Paul M,Bilancia Rossella,Rossi Antonietta,Gür Maz Tuğçe^ORCID,Banoglu Erden^ORCID,Schubert Ulrich S,Werz Oliver^ORCID

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Eicosanoids

2. Pro-resolving lipid mediators are leads for resolution physiology

3. Selectivity of phospholipid hydrolysis by phospholipase A2 enzymes in activated cells leading to polyunsaturated fatty acid mobilization

4. Specialized pro-resolving mediator network: an update on production and actions

5. Eicosanoid storm in infection and inflammation

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes;Journal of Clinical Medicine;2024-07-21

2. Dual Anti-Inflammatory Activities of COX-2/5-LOX Driven by Kratom Alkaloid Extracts in Lipopolysaccharide-induced RAW 264.7 Cells;2024-06-25

3. Reorganization of innate immune cell lipid profiles by bioinspired meroterpenoids to limit inflammation;2024-05-28

4. PEG–Lipid–PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs;Pharmaceutics;2024-01-28

5. Arachidonic acid-derived lipid mediators in multiple sclerosis pathogenesis: fueling or dampening disease progression?;Journal of Neuroinflammation;2024-01-17